Maximizing tuberculosis services through private provider engagement – A case study from Pakistan

IF 2 Q3 INFECTIOUS DISEASES
Aamna Rashid , Surbhi Sheokand , Razia Fatima , Hammad Habib , Adeel Tahir , Asim Saleem , Poshan Thapa , Petra Heitkamp
{"title":"Maximizing tuberculosis services through private provider engagement – A case study from Pakistan","authors":"Aamna Rashid ,&nbsp;Surbhi Sheokand ,&nbsp;Razia Fatima ,&nbsp;Hammad Habib ,&nbsp;Adeel Tahir ,&nbsp;Asim Saleem ,&nbsp;Poshan Thapa ,&nbsp;Petra Heitkamp","doi":"10.1016/j.jctube.2024.100506","DOIUrl":null,"url":null,"abstract":"<div><div>Pakistan is the fourth highest contributor to the globally estimated 3.7 million tuberculosis (TB) cases. Due to the subpar condition of public sector facilities in Pakistan, the private sector remains the preferred choice, with over 90% of people accessing it for TB care. Aligning with the World Health Organization’s (WHO) patient-centered approach, the private provider engagement program led by Mercy Corps (MC) and supported by the Global Fund has been actively engaging the private sector for over a decade in strengthening Pakistan’s TB services through innovative interventions. Their public–private mix (PPM) strategies like, involving General Practitioners (GPs), large private hospitals, pharmacies, specimen transportation and mobile outreach chest camps, take an integrated approach (Fig. 1) to ensure treatment adherence, completion, and contact screening in reaching the last mile. In this paper, we present MC’s contributions as a case study to elaborate on the crucial role of private provider engagement in improving overall TB care, increasing TB notifications, and addressing the urgent need to identify people with undiagnosed TB.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"39 ","pages":"Article 100506"},"PeriodicalIF":2.0000,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405579424000937","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Pakistan is the fourth highest contributor to the globally estimated 3.7 million tuberculosis (TB) cases. Due to the subpar condition of public sector facilities in Pakistan, the private sector remains the preferred choice, with over 90% of people accessing it for TB care. Aligning with the World Health Organization’s (WHO) patient-centered approach, the private provider engagement program led by Mercy Corps (MC) and supported by the Global Fund has been actively engaging the private sector for over a decade in strengthening Pakistan’s TB services through innovative interventions. Their public–private mix (PPM) strategies like, involving General Practitioners (GPs), large private hospitals, pharmacies, specimen transportation and mobile outreach chest camps, take an integrated approach (Fig. 1) to ensure treatment adherence, completion, and contact screening in reaching the last mile. In this paper, we present MC’s contributions as a case study to elaborate on the crucial role of private provider engagement in improving overall TB care, increasing TB notifications, and addressing the urgent need to identify people with undiagnosed TB.
通过私营机构参与最大限度地提高结核病服务——来自巴基斯坦的案例研究
巴基斯坦是全球估计370万结核病病例的第四大贡献者。由于巴基斯坦公共部门设施条件欠佳,私营部门仍然是首选,90%以上的人通过私营部门获得结核病治疗。根据世界卫生组织(世卫组织)以患者为中心的方针,由美济会(Mercy Corps)领导并得到全球基金支持的私营提供者参与规划十多年来一直积极参与私营部门,通过创新干预措施加强巴基斯坦的结核病服务。他们的公私混合(PPM)策略,如涉及全科医生(gp)、大型私立医院、药店、标本运输和移动外展胸营,采取综合方法(图1),以确保治疗的依从性、完成性和接触筛查,直到最后一英里。在本文中,我们将MC作为一个案例研究来阐述私人提供者参与在改善整体结核病治疗、增加结核病通报和解决识别未确诊结核病患者的迫切需要方面的关键作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases Medicine-Pulmonary and Respiratory Medicine
CiteScore
4.00
自引率
5.00%
发文量
44
审稿时长
30 weeks
期刊介绍: Journal of Clinical Tuberculosis and Mycobacterial Diseases aims to provide a forum for clinically relevant articles on all aspects of tuberculosis and other mycobacterial infections, including (but not limited to) epidemiology, clinical investigation, transmission, diagnosis, treatment, drug-resistance and public policy, and encourages the submission of clinical studies, thematic reviews and case reports. Journal of Clinical Tuberculosis and Mycobacterial Diseases is an Open Access publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信